47045-BLZ-H-SSB
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Getting to 90-90-90
Belize - HIV - Social Security Board - SSB. This program has the following goals: Deliver tailored combination prevention package of services to MSM, TGs, and their partners.. Strengthen Linkage to Care for persons testing positive for HIV through expanded community outreach and greater engagement of CSOs. Expand treatment coverage for HIV/STIs & TB. Reduce the burden of TB among PLHIV through increased case findings, IPT prophylaxis and enhanced infection control practices. Strengthen advocacy for pro health legislations and initiatives to remove legal, institutional and service delivery barriers.. The objectives of this program are: By 2025, 90% MSM would have had an HIV test in the last 12 months.. By 2025, 90% of PLHIV know their HIV status. By 2025, 90% of PLHIV who know their status are on ARVS.. By 2025, 90% of PLHIV on treatment achieve viral suppression. By 2025, number of AIDS related deaths reduced to less than five.. By 2025, achieve 95% treatment success rate for TB/HIV coinfection.. Achieve zero discrimination in the health care setting by 2025
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Social Security Board
Social Security Board
CCM Belize
CCM Belize
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
Belize
HIV
Health Products - Non-Pharmaceuticals (HPNP)
Human Resources (HR)
Payment for Results
Living support to client/ target population (LSCTP)
External Professional services (EPS)
Communication Material and Publications (CMP)
Travel related costs (TRC)
Indirect and Overhead Costs
Procurement and Supply-Chain Management costs (PSM)
Health Products - Equipment (HPE)
Infrastructure (INF)
Non-health equipment (NHP)
483043.78
535699.93
239044.32
585838.49
182429.16
392863.83
198115.86
100870.58
196570.05
276219.76
343444.76
187976.27
83280.00
Global Fund Commitment to BLZ-H-SSB.
56284.92
Global Fund Commitment to BLZ-H-SSB.
49337.63
Global Fund Commitment to BLZ-H-SSB.
-320.11
Global Fund Commitment to BLZ-H-SSB.
16670.72
Global Fund Commitment to BLZ-H-SSB.
56284.92
Global Fund Commitment to BLZ-H-SSB.
2775.28
Global Fund Commitment to BLZ-H-SSB.
-55044.11
Global Fund Commitment to BLZ-H-SSB.
-39842.67
Global Fund Commitment to BLZ-H-SSB.
-4402.70
Global Fund Commitment to BLZ-H-SSB.
-49337.63
Global Fund Commitment to BLZ-H-SSB.
68994.73
Global Fund Commitment to BLZ-H-SSB.
-264041.00
Global Fund Commitment to BLZ-H-SSB.
-1250.28
Global Fund Commitment to BLZ-H-SSB.
-1456.94
Global Fund Commitment to BLZ-H-SSB.
-31311.36
Global Fund Commitment to BLZ-H-SSB.
98466.05
Global Fund Commitment to BLZ-H-SSB.
-98466.05
Global Fund Commitment to BLZ-H-SSB.
128307.23
Global Fund Commitment to BLZ-H-SSB.
-1456.94
Global Fund Commitment to BLZ-H-SSB.
55044.11
Global Fund Commitment to BLZ-H-SSB.
-15201.44
Global Fund Commitment to BLZ-H-SSB.
1456.94
Global Fund Commitment to BLZ-H-SSB.
10717.80
Global Fund Commitment to BLZ-H-SSB.
1009594.85
Global Fund Commitment to BLZ-H-SSB.
29841.18
Global Fund Commitment to BLZ-H-SSB.
1600055.00
Global Fund Commitment to BLZ-H-SSB.
-1240.81
Global Fund Commitment to BLZ-H-SSB.
21289.95
Global Fund disbursement to BLZ-H-SSB.
-15201.44
Global Fund disbursement to BLZ-H-SSB.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
8522.84
Global Fund disbursement to BLZ-H-SSB.
48558.75
Global Fund disbursement to BLZ-H-SSB.
288261.68
Global Fund disbursement to BLZ-H-SSB.
4148.53
Global Fund disbursement to BLZ-H-SSB.
99804.97
Global Fund disbursement to BLZ-H-SSB.
1240.81
Global Fund disbursement to BLZ-H-SSB.
83280.00
Global Fund disbursement to BLZ-H-SSB.
15201.44
Global Fund disbursement to BLZ-H-SSB.
1240.81
Global Fund disbursement to BLZ-H-SSB.
-1456.94
Global Fund disbursement to BLZ-H-SSB.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
10717.80
Global Fund disbursement to BLZ-H-SSB.
273541.95
Global Fund disbursement to BLZ-H-SSB.
1142502.00
Global Fund disbursement to BLZ-H-SSB.
12384.14
Global Fund disbursement to BLZ-H-SSB.
15201.44
Global Fund disbursement to BLZ-H-SSB.
1815.27
Global Fund disbursement to BLZ-H-SSB.
96995.87
Global Fund disbursement to BLZ-H-SSB.
-1240.81
Global Fund disbursement to BLZ-H-SSB.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
339463.41
Global Fund disbursement to BLZ-H-SSB.
2455.17
Global Fund disbursement to BLZ-H-SSB.
-1250.28
Global Fund disbursement to BLZ-H-SSB.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
16670.72
Global Fund disbursement to BLZ-H-SSB.
193512.00
Global Fund disbursement to BLZ-H-SSB.
Coverage / Output indicator for BLZ-H-SSB
Percentage of transgender people that have received an HIV test during the reporting period and know their results
Numerator: 238 Denominator: 596 Percentage: 39.93
Numerator: 238 Denominator: 596 Percentage: 40.00
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 4 Denominator: 596 Percentage: 0.30
Numerator: 4 Denominator: 596 Percentage: 0.30
Numerator: 357 Denominator: 596 Percentage: 60.00
Numerator: 357 Denominator: 596 Percentage: 59.90
Percentage of people on ART among all people living with HIV at the end of the reporting period
Numerator: 1490 Denominator: 5504 Percentage: 27.07
Numerator: 1561 Denominator: 3515 Percentage: 44.41
Numerator: 1490 Denominator: 5504 Percentage: 27.07
Numerator: 2460 Denominator: 3515 Percentage: 69.99
Numerator: 3780 Denominator: 5404 Percentage: 70.00
Numerator: 2812 Denominator: 3515 Percentage: 80.00
Numerator: 4320 Denominator: 5404 Percentage: 80.00
Numerator: 2700 Denominator: 5404 Percentage: 50.00
Numerator: 2700 Denominator: 5404 Percentage: 50.00
Numerator: 2700 Denominator: 5404 Percentage: 50.00
Numerator: 1638 Denominator: 3515 Percentage: 46.70
Numerator: 1638 Denominator: 3515 Percentage: 46.70
Number of MSM who received any PrEP product at least once during the reporting period
Numerator: 737 Denominator: 737 Percentage: 100.00
Numerator: 578 Denominator: 578 Percentage: 100.00
Numerator: 425 Denominator: 425 Percentage: 100.00
Percentage of eligible transgender people who initiated oral antiretroviral PrEP during the reporting period
Numerator: 121 Denominator: 121 Percentage: 100.00
Numerator: 121 Denominator: 121 Percentage: 100.00
Numerator: 85 Denominator: 85 Percentage: 100.00
Numerator: 85 Denominator: 85 Percentage: 100.00
Numerator: 50 Denominator: 50 Percentage: 100.00
Numerator: 50 Denominator: 50 Percentage: 100.00
Numerator: 50 Denominator: 50 Percentage: 100.00
Percentage of men who have sex with men reached with HIV prevention programs - defined package of services
Numerator: 1595 Denominator: 9891 Percentage: 16.13
Numerator: 1595 Denominator: 9891 Percentage: 16.13
Numerator: 4940 Denominator: 9891 Percentage: 50.00
Numerator: 4940 Denominator: 9891 Percentage: 49.94
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 739 Denominator: 9891 Percentage: 5.60
Numerator: 739 Denominator: 9891 Percentage: 5.60
Numerator: 6920 Denominator: 9891 Percentage: 69.96
Numerator: 6920 Denominator: 9891 Percentage: 70.00
Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results
Numerator: 1355 Denominator: 9891 Percentage: 13.70
Numerator: 1355 Denominator: 9891 Percentage: 13.70
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 699 Denominator: 9891 Percentage: 5.20
Numerator: 699 Denominator: 9891 Percentage: 5.20
Numerator: 4940 Denominator: 9891 Percentage: 50.00
Numerator: 4940 Denominator: 9891 Percentage: 49.94
Numerator: 6920 Denominator: 9891 Percentage: 70.00
Numerator: 6920 Denominator: 9891 Percentage: 69.96
Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results
Numerator: 357 Denominator: 596 Percentage: 60.00
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 238 Denominator: 596 Percentage: 40.00
Percentage of eligible men who have sex with men who initiated oral antiretroviral PrEP during the reporting period
Numerator: 578 Denominator: 578 Percentage: 100.00
Numerator: 578 Denominator: 578 Percentage: 100.00
Numerator: 425 Denominator: 425 Percentage: 100.00
Numerator: 425 Denominator: 425 Percentage: 100.00
Numerator: 425 Denominator: 425 Percentage: 100.00
Numerator: 6 Denominator: 27 Percentage: 27.30
Numerator: 6 Denominator: 27 Percentage: 27.30
Numerator: 737 Denominator: 737 Percentage: 100.00
Numerator: 737 Denominator: 737 Percentage: 100.00
Percentage of transgender people reached with HIV prevention programs - defined package of services
Numerator: 20 Denominator: 596 Percentage: 3.36
Numerator: 20 Denominator: 596 Percentage: 3.36
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 119 Denominator: 596 Percentage: 20.00
Numerator: 4 Denominator: 596 Percentage: 0.30
Numerator: 4 Denominator: 596 Percentage: 0.30
Numerator: 238 Denominator: 596 Percentage: 40.00
Numerator: 238 Denominator: 596 Percentage: 39.93
Numerator: 357 Denominator: 596 Percentage: 59.90
Numerator: 357 Denominator: 596 Percentage: 60.00
Number of transgender people who received any PrEP product at least once during the reporting period
Numerator: 50 Denominator: 50 Percentage: 100.00
Numerator: 121 Denominator: 121 Percentage: 100.00
Numerator: 85 Denominator: 85 Percentage: 100.00
Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results
Numerator: 1355 Denominator: 9891 Percentage: 13.70
Numerator: 2960 Denominator: 9891 Percentage: 30.00
Numerator: 6920 Denominator: 9891 Percentage: 70.00
Numerator: 4940 Denominator: 9891 Percentage: 50.00
47045-BLZ-C-UNDP
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Building Resilience Through Innovation and National Accountability
Belize - TB/HIV - United Nations Development Programme - UNDP Belize.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
United Nations Development Programme
United Nations Development Programme
CCM Belize
CCM Belize
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
Belize
TB/HIV
External Professional services (EPS)
Human Resources (HR)
Indirect and Overhead Costs
Living support to client/ target population (LSCTP)
Non-health equipment (NHP)
Travel related costs (TRC)
Health Products - Equipment (HPE)
Health Products - Pharmaceutical Products (HPPP)
Health Products - Non-Pharmaceuticals (HPNP)
Procurement and Supply-Chain Management costs (PSM)
Communication Material and Publications (CMP)
185762.16
142300.21
485120.00
158158.06
216632.10
125494.56
389271.86
233752.65
159274.57
302630.41
125026.71
147670.62
430747.67
Global Fund Commitment to BLZ-C-UNDP.
-624.48
Global Fund Commitment to BLZ-C-UNDP.
-110459.03
Global Fund Commitment to BLZ-C-UNDP.
602857.60
Global Fund Commitment to BLZ-C-UNDP.
1035991.00
Global Fund Commitment to BLZ-C-UNDP.
526486.00
Global Fund Commitment to BLZ-C-UNDP.
1040059.00
Global Fund Commitment to BLZ-C-UNDP.
1891734.00
Global Fund Commitment to BLZ-C-UNDP.
94285.00
Global Fund Commitment to BLZ-C-UNDP.
26857.46
Global Fund Commitment to BLZ-C-UNDP.
-4385.00
Global Fund Commitment to BLZ-C-UNDP.
160974.00
Global Fund disbursement to BLZ-C-UNDP.
408363.00
Global Fund disbursement to BLZ-C-UNDP.
215117.00
Global Fund disbursement to BLZ-C-UNDP.
136815.00
Global Fund disbursement to BLZ-C-UNDP.
526486.00
Global Fund disbursement to BLZ-C-UNDP.
198569.00
Global Fund disbursement to BLZ-C-UNDP.
-624.48
Global Fund disbursement to BLZ-C-UNDP.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
1887349.00
Global Fund disbursement to BLZ-C-UNDP.
237219.85
Global Fund disbursement to BLZ-C-UNDP.
-110459.03
Global Fund disbursement to BLZ-C-UNDP.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
165625.00
Global Fund disbursement to BLZ-C-UNDP.
320427.00
Global Fund disbursement to BLZ-C-UNDP.
211945.17
Global Fund disbursement to BLZ-C-UNDP.
145644.00
Global Fund disbursement to BLZ-C-UNDP.
430747.67
Global Fund disbursement to BLZ-C-UNDP.
26857.46
Global Fund disbursement to BLZ-C-UNDP.
186271.00
Global Fund disbursement to BLZ-C-UNDP.
94285.00
Global Fund disbursement to BLZ-C-UNDP.
138245.00
Global Fund disbursement to BLZ-C-UNDP.
153692.58
Global Fund disbursement to BLZ-C-UNDP.
Coverage / Output indicator for BLZ-C-UNDP
Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases
Numerator: 15 Denominator: 33 Percentage: 45.45
Numerator: 17 Denominator: 33 Percentage: 51.52
Numerator: 1 Denominator: 33 Percentage: 3.03
Numerator: 74 Denominator: 120 Percentage: 61.67
Numerator: 1 Denominator: 33 Percentage: 3.03
Numerator: 3 Denominator: 33 Percentage: 9.09
Numerator: 15 Denominator: 33 Percentage: 45.45
Numerator: 3 Denominator: 33 Percentage: 9.09
Numerator: 74 Denominator: 120 Percentage: 61.67
Numerator: 17 Denominator: 33 Percentage: 51.52
Numerator: 43 Denominator: 72 Percentage: 59.70
Numerator: 43 Denominator: 72 Percentage: 59.70
Numerator: 74 Denominator: 120 Percentage: 61.67
Percentage: 85.00
Percentage: 85.00
Percentage: 85.00
Percentage: 85.00
Percentage: 85.00
Percentage: 85.00
Percentage: 85.00
Percentage: 85.00
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Numerator: 66 Denominator: 81 Percentage: 81.50
Percentage: 86.00
Percentage: 86.00
Numerator: 82 Denominator: 116 Percentage: 70.70
Numerator: 63 Denominator: 83 Percentage: 75.90
Numerator: 1 Denominator: 1 Percentage: 100.00
Numerator: 18 Denominator: 28 Percentage: 64.30
Numerator: 45 Denominator: 67 Percentage: 67.20
Numerator: 83 Denominator: 117 Percentage: 70.90
Numerator: 2 Denominator: 6 Percentage: 33.30
Numerator: 38 Denominator: 50 Percentage: 76.00
Numerator: 1 Denominator: 1 Percentage: 100.00
Numerator: 82 Denominator: 116 Percentage: 70.70
Numerator: 38 Denominator: 50 Percentage: 76.00
Numerator: 63 Denominator: 83 Percentage: 75.90
Numerator: 45 Denominator: 67 Percentage: 67.20
Numerator: 83 Denominator: 117 Percentage: 70.90
Numerator: 18 Denominator: 28 Percentage: 64.30
Numerator: 2 Denominator: 6 Percentage: 33.30
Percentage: 77.50
Percentage: 77.50
Percentage: 77.50
Numerator: 64 Denominator: 91 Percentage: 70.30
Numerator: 64 Denominator: 91 Percentage: 70.30
Numerator: 64 Denominator: 91 Percentage: 70.30
Percentage: 60.00
Percentage: 60.00
Numerator: 52 Denominator: 78 Percentage: 66.70
Numerator: 52 Denominator: 78 Percentage: 66.70
Percentage: 70.00
Percentage: 70.00
Percentage: 70.00
Numerator: 63 Denominator: 99 Percentage: 63.60
Numerator: 63 Denominator: 99 Percentage: 63.60
Numerator: 63 Denominator: 99 Percentage: 63.60
Percentage: 70.00
Percentage: 70.00
Numerator: 74 Denominator: 120 Percentage: 61.70
Numerator: 74 Denominator: 120 Percentage: 61.70
Number of cases with RR-TB and/or MDR-TB that began second-line treatment
Numerator: 0
Numerator: 0
Numerator: 5
Numerator: 5
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 3
Numerator: 3
Numerator: 0
Numerator: 0
Percentage of people living with HIV currently receiving antiretroviral therapy
Numerator: 132 Denominator: 1460 Percentage: 9.04
Numerator: 1354 Denominator: 4391 Percentage: 30.84
Numerator: 132 Denominator: 1460 Percentage: 9.04
Numerator: 1354 Denominator: 4391 Percentage: 30.84
Numerator: 1328 Denominator: 1460 Percentage: 91.00
Numerator: 1328 Denominator: 1460 Percentage: 91.00
Numerator: 1183 Denominator: 2897 Percentage: 40.80
Numerator: 3050 Denominator: 4836 Percentage: 63.10
Numerator: 3050 Denominator: 4836 Percentage: 63.07
Numerator: 1490 Denominator: 4836 Percentage: 30.80
Numerator: 1490 Denominator: 4836 Percentage: 30.80
Numerator: 3500 Denominator: 5016 Percentage: 69.80
Numerator: 3500 Denominator: 5016 Percentage: 69.78
Numerator: 3500 Denominator: 5016 Percentage: 69.80
Numerator: 3500 Denominator: 5016 Percentage: 69.80
Numerator: 1626 Denominator: 4124 Percentage: 39.40
Numerator: 1626 Denominator: 4124 Percentage: 39.40
Numerator: 1626 Denominator: 4124 Percentage: 39.40
Numerator: 1626 Denominator: 4124 Percentage: 39.40
Numerator: 1509 Denominator: 3332 Percentage: 45.30
Numerator: 1460 Denominator: 3332 Percentage: 43.80
Numerator: 1343 Denominator: 3191 Percentage: 42.10
Numerator: 1242 Denominator: 3191 Percentage: 38.90
Numerator: 1662 Denominator: 3474 Percentage: 47.80
Numerator: 1486 Denominator: 3474 Percentage: 42.80
Numerator: 2550 Denominator: 4671 Percentage: 54.60
Numerator: 2550 Denominator: 4671 Percentage: 54.60
Numerator: 1530 Denominator: 4671 Percentage: 32.80
Numerator: 1530 Denominator: 4671 Percentage: 32.80
Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases
Numerator: 117
Numerator: 587 Denominator: 2897 Percentage: 20.26
Numerator: 72
Numerator: 0 Denominator: 2897 Percentage: 0.00
Numerator: 73 Denominator: 2897 Percentage: 2.52
Numerator: 117
Numerator: 72
Numerator: 596 Denominator: 2897 Percentage: 20.57
Numerator: 117
Numerator: 596 Denominator: 2897 Percentage: 20.57
Numerator: 587 Denominator: 2897 Percentage: 20.26
Numerator: 73 Denominator: 2897 Percentage: 2.52
Numerator: 0 Denominator: 2897 Percentage: 0.00
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 81
Numerator: 81
Numerator: 81
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 95
Numerator: 72
Numerator: 72
Numerator: 72
Numerator: 72
Numerator: 72
Numerator: 72
Numerator: 72
Numerator: 72
Numerator: 120
Numerator: 120
Numerator: 120
Numerator: 91
Numerator: 91
Numerator: 91
Numerator: 49
Numerator: 49
Numerator: 37
Numerator: 62
Numerator: 99
Numerator: 64
Numerator: 99
Numerator: 62
Numerator: 99
Numerator: 4
Numerator: 31
Numerator: 57
Numerator: 0
Numerator: 64
Numerator: 31
Numerator: 99
Numerator: 37
Numerator: 0
Numerator: 4
Numerator: 57
Numerator: 54
Numerator: 54
Numerator: 117
Numerator: 117
Numerator: 49
Numerator: 49
Percentage of MSM that have received an HIV test during the reporting period and know their results
Numerator: 300 Denominator: 2312 Percentage: 13.00
Numerator: 700 Denominator: 2618 Percentage: 26.70
Numerator: 699 Denominator: 2618 Percentage: 26.70
Numerator: 450 Denominator: 2486 Percentage: 18.10
Numerator: 452 Denominator: 2486 Percentage: 18.20
Numerator: 550 Denominator: 2551 Percentage: 21.60
Numerator: 571 Denominator: 2551 Percentage: 22.40
Percentage of men who have sex with men reached with HIV prevention programs - defined package of services
Numerator: 540 Denominator: 2551 Percentage: 21.17
Numerator: 540 Denominator: 2551 Percentage: 21.17
Numerator: 540 Denominator: 2551 Percentage: 21.17
Numerator: 1058 Denominator: 3689 Percentage: 29.00
Numerator: 1058 Denominator: 3689 Percentage: 29.00
Numerator: 1058 Denominator: 3689 Percentage: 29.00
Numerator: 1040 Denominator: 3689 Percentage: 28.20
Numerator: 1040 Denominator: 3689 Percentage: 28.20
Numerator: 1040 Denominator: 3689 Percentage: 28.20
Numerator: 1424 Denominator: 3755 Percentage: 37.92
Numerator: 1424 Denominator: 3755 Percentage: 37.90
Numerator: 1424 Denominator: 3755 Percentage: 37.92
Numerator: 1595 Denominator: 3755 Percentage: 42.50
Numerator: 1595 Denominator: 3755 Percentage: 42.50
Numerator: 1595 Denominator: 3755 Percentage: 42.50
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1900 Denominator: 3823 Percentage: 49.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Numerator: 1860 Denominator: 3823 Percentage: 48.70
Percentage of MSM reached with HIV prevention programs - defined package of services
Numerator: 300 Denominator: 2312 Percentage: 13.00
Numerator: 700 Denominator: 2618 Percentage: 26.70
Numerator: 699 Denominator: 2618 Percentage: 26.70
Numerator: 550 Denominator: 2551 Percentage: 21.60
Numerator: 540 Denominator: 2551 Percentage: 21.20
Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services
Numerator: 5349 Denominator: 46238 Percentage: 11.60
Numerator: 5349 Denominator: 46238 Percentage: 11.60
Numerator: 11700 Denominator: 51029 Percentage: 22.90
Numerator: 11700 Denominator: 51029 Percentage: 22.90
Numerator: 10919 Denominator: 51209 Percentage: 21.30
Numerator: 10919 Denominator: 51209 Percentage: 21.30
Numerator: 14000 Denominator: 52366 Percentage: 26.70
Numerator: 14000 Denominator: 52366 Percentage: 26.70
Numerator: 11180 Denominator: 52366 Percentage: 21.40
Numerator: 11180 Denominator: 52366 Percentage: 21.40
Number of TB cases with RR-TB and/or MDR-TB notified
Numerator: 0
Numerator: 0
Numerator: 5
Numerator: 5
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 0
Numerator: 2
Numerator: 2
Numerator: 3
Numerator: 3
Numerator: 1
Numerator: 1
Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results
Numerator: 5349 Denominator: 46238 Percentage: 11.60
Numerator: 5349 Denominator: 46238 Percentage: 11.60
Numerator: 8500 Denominator: 49725 Percentage: 17.10
Numerator: 8500 Denominator: 49725 Percentage: 17.10
Numerator: 7469 Denominator: 49725 Percentage: 15.00
Numerator: 7469 Denominator: 49725 Percentage: 15.00
Numerator: 11700 Denominator: 51029 Percentage: 22.90
Numerator: 11700 Denominator: 51029 Percentage: 22.90
Numerator: 10919 Denominator: 51209 Percentage: 21.30
Numerator: 10919 Denominator: 51209 Percentage: 21.30
Numerator: 14000 Denominator: 52366 Percentage: 26.70
Numerator: 14000 Denominator: 52366 Percentage: 26.70
Numerator: 11180 Denominator: 52366 Percentage: 21.40
Numerator: 11180 Denominator: 52366 Percentage: 21.40
Percentage of HIV-positive new and relapse TB patients on ART during TB treatment
Numerator: 11 Denominator: 14 Percentage: 78.60
Numerator: 28 Denominator: 30 Percentage: 93.30
Numerator: 27 Denominator: 28 Percentage: 96.40
Numerator: 34 Denominator: 35 Percentage: 97.10
Numerator: 28 Denominator: 31 Percentage: 90.30
47045-BEL-910-G02-H
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Belize - HIV - United Nations Development Programme
Belize - HIV - United Nations Development Programme - UNDP Belize.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
United Nations Development Programme
United Nations Development Programme
CCM Belize
CCM Belize
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
Belize
HIV
570039.00
Global Fund Commitment to BEL-910-G02-H.
1450840.00
Global Fund Commitment to BEL-910-G02-H.
752369.00
Global Fund Commitment to BEL-910-G02-H.
-60445.44
Global Fund Commitment to BEL-910-G02-H.
-270039.00
Global Fund Commitment to BEL-910-G02-H.
2929919.00
Global Fund Commitment to BEL-910-G02-H.
456917.00
Global Fund disbursement to BEL-910-G02-H.
752369.00
Global Fund disbursement to BEL-910-G02-H.
406777.00
Global Fund disbursement to BEL-910-G02-H.
993923.00
Global Fund disbursement to BEL-910-G02-H.
546968.00
Global Fund disbursement to BEL-910-G02-H.
100000.00
Global Fund disbursement to BEL-910-G02-H.
996973.00
Global Fund disbursement to BEL-910-G02-H.
979201.00
Global Fund disbursement to BEL-910-G02-H.
200000.00
Global Fund disbursement to BEL-910-G02-H.
-60445.44
Global Fund disbursement to BEL-910-G02-H.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
47045-BLZ-304-G01-H
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Belize - HIV - Belize Enterprise for Sustainable Technology
Belize - HIV - Belize Enterprise for Sustainable Technology.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Belize Enterprise for Sustainable Technology
Belize Enterprise for Sustainable Technology
CCM Belize
CCM Belize
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Grant Management Division
Carmen GONZALEZ
Fund Portfolio Manager
+41 58 791 1700
carmen.gonzalez@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
The Global Fund to Fight AIDS Tuberculosis and Malaria
Communications
Murad HIRJI
Senior Digital Architect
+41 58 791 1700
murad.hirji@theglobalfund.org
https://www.theglobalfund.org
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland
Belize
HIV
2097976.00
Global Fund Commitment to BLZ-304-G01-H.
68977.00
Global Fund disbursement to BLZ-304-G01-H.
226687.00
Global Fund disbursement to BLZ-304-G01-H.
58202.25
Global Fund disbursement to BLZ-304-G01-H.
61835.00
Global Fund disbursement to BLZ-304-G01-H.
-34730.00
Global Fund disbursement to BLZ-304-G01-H.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
119309.19
Global Fund disbursement to BLZ-304-G01-H.
342578.00
Global Fund disbursement to BLZ-304-G01-H.
66729.00
Global Fund disbursement to BLZ-304-G01-H.
282476.00
Global Fund disbursement to BLZ-304-G01-H.
126894.00
Global Fund disbursement to BLZ-304-G01-H.
63878.77
Global Fund disbursement to BLZ-304-G01-H.
-49797.21
Global Fund disbursement to BLZ-304-G01-H.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
114047.00
Global Fund disbursement to BLZ-304-G01-H.
141170.00
Global Fund disbursement to BLZ-304-G01-H.
249345.00
Global Fund disbursement to BLZ-304-G01-H.
260375.00
Global Fund disbursement to BLZ-304-G01-H.